kallikrein-1 inhibitors (Dyax)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namekallikrein-1 inhibitors (Dyax)
Drug Alias NameDX-2300
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDyax Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDyax Corp
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A